A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
Clinical trial NCT06118515 · COMPLETED
Trial details
- NCT number
- NCT06118515
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2026-04-07
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.